Epidemiological, pathological and metabolomic characterisation of an acquired myopathy of dogs in New Zealand
0 sources
Epidemiological, pathological and metabolomic characterisation of an acquired myopathy of dogs in New Zealand
Summary
Epidemiological, pathological and metabolomic characterisation of an acquired myopathy of dogs in New Zealand is a doctoral thesis[1].
Key Facts
- Epidemiological, pathological and metabolomic characterisation of an acquired myopathy of dogs in New Zealand authored Hayley Hunt[2].
- Epidemiological, pathological and metabolomic characterisation of an acquired myopathy of dogs in New Zealand's instance of is recorded as doctoral thesis[3].
- Epidemiological, pathological and metabolomic characterisation of an acquired myopathy of dogs in New Zealand's publisher is recorded as Massey Research Online[4].
- Epidemiological, pathological and metabolomic characterisation of an acquired myopathy of dogs in New Zealand's language of work or name is recorded as English[5].
- Epidemiological, pathological and metabolomic characterisation of an acquired myopathy of dogs in New Zealand's country of origin is recorded as New Zealand[6].
- Epidemiological, pathological and metabolomic characterisation of an acquired myopathy of dogs in New Zealand's publication date is recorded as +2018-00-00T00:00:00Z[7].
- Epidemiological, pathological and metabolomic characterisation of an acquired myopathy of dogs in New Zealand's main subject is recorded as New Zealand[8].
- Epidemiological, pathological and metabolomic characterisation of an acquired myopathy of dogs in New Zealand's main subject is recorded as Northland Region[9].
- Epidemiological, pathological and metabolomic characterisation of an acquired myopathy of dogs in New Zealand's main subject is recorded as disease[10].
- Epidemiological, pathological and metabolomic characterisation of an acquired myopathy of dogs in New Zealand's main subject is recorded as epizootiology[11].
- Epidemiological, pathological and metabolomic characterisation of an acquired myopathy of dogs in New Zealand's main subject is recorded as epidemiology[12].
- Epidemiological, pathological and metabolomic characterisation of an acquired myopathy of dogs in New Zealand's Handle ID is recorded as 10179/14413[13].
- Epidemiological, pathological and metabolomic characterisation of an acquired myopathy of dogs in New Zealand's title is recorded as Epidemiological, pathological and metabolomic characterisation of an acquired myopathy of dogs in New Zealand[14].
- Epidemiological, pathological and metabolomic characterisation of an acquired myopathy of dogs in New Zealand's copyright holder is recorded as Hayley Hunt[15].
- Epidemiological, pathological and metabolomic characterisation of an acquired myopathy of dogs in New Zealand's thesis submitted to is recorded as Massey University[16].
- Epidemiological, pathological and metabolomic characterisation of an acquired myopathy of dogs in New Zealand's on focus list of Wikimedia project is recorded as NZThesisProject[17].
- Epidemiological, pathological and metabolomic characterisation of an acquired myopathy of dogs in New Zealand's copyright status is recorded as copyrighted[18].
- Epidemiological, pathological and metabolomic characterisation of an acquired myopathy of dogs in New Zealand's thesis committee member is recorded as Wendi Roe[19].
- Epidemiological, pathological and metabolomic characterisation of an acquired myopathy of dogs in New Zealand's thesis committee member is recorded as Brett Gartrell[20].
- Epidemiological, pathological and metabolomic characterisation of an acquired myopathy of dogs in New Zealand's thesis committee member is recorded as Nick Cave[21].
- Epidemiological, pathological and metabolomic characterisation of an acquired myopathy of dogs in New Zealand's thesis committee member is recorded as Karl Fraser[22].
Body
Designation and Status
Epidemiological, pathological and metabolomic characterisation of an acquired myopathy of dogs in New Zealand's instance of is recorded as doctoral thesis[3].